Ken Song's T Cell Engager Bet Gets Picked Up
Ken Song has done it again.
Ken Song has done it again.
FDA cleared Veppanu on Friday as the first-ever PROTAC therapy, a new drug class that actively degrades disease-causing proteins rather than just blocking them.
UCB bought Candid Therapeutics for $2 billion upfront, plus up to $200 million in development milestones, cutting off a planned reverse merger with…
Pfizer sold gedatolisib to Celcuity for $10 million upfront in 2021.
Microsoft's Defender antivirus flagged legitimate DigiCert root certificates as Trojan:Win32/Cerdigent.
A criminal threat actor hit Instructure, the company behind the Canvas learning management system, in a cyberattack disclosed this week.
FDA cleared Veppanu (vepdegestrant) on Friday, a month ahead of its June 5 PDUFA date, making the Pfizer-Arvinas collaboration the first to take a PROTAC…
Novartis has committed $23 billion to build seven U.S. facilities, and the final piece just landed in Morrisville, North Carolina: a 56,200-square-foot…
FDA approved Axsome Therapeutics' Auvelity for agitation in Alzheimer's disease patients.
Moderna told FDA it will provide post-marketing data on its Covid-19 vaccines to restore access to a broader population, the company confirmed May 1.
Six government cybersecurity agencies from the US, UK, Australia, Canada, and New Zealand just told every operator running agentic AI in production: your…
Minnesota's new nudification law applies to any company that makes AI tools capable of generating fake intimate images — and it targets the moment of…
$166 million in annual compliance savings sounds like a win.
The UK Serious Fraud Office secured a court-approved Deferred Prosecution Agreement with Ultra Electronics Holdings Ltd, a British manufacturer of…
The FCC voted unanimously Wednesday to tighten Know Your Customer rules for U.S. telecoms, closing a loophole dating to 1999 that let foreign companies…